Rainer Kleemann

963 total citations
17 papers, 781 citations indexed

About

Rainer Kleemann is a scholar working on Surgery, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Rainer Kleemann has authored 17 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Genetics and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Rainer Kleemann's work include Diabetes and associated disorders (5 papers), Pancreatic function and diabetes (3 papers) and Antimicrobial Peptides and Activities (2 papers). Rainer Kleemann is often cited by papers focused on Diabetes and associated disorders (5 papers), Pancreatic function and diabetes (3 papers) and Antimicrobial Peptides and Activities (2 papers). Rainer Kleemann collaborates with scholars based in Germany, Canada and United Kingdom. Rainer Kleemann's co-authors include Hubert Kolb, Stéphan Martin, Kerstin Bellmann, Fraser W. Scott, H. Rothe, J Radons, A Wenz, Volker Burkart, Paul Rowsell and Carl Nathan and has published in prestigious journals such as Journal of Clinical Investigation, Diabetes and FEBS Letters.

In The Last Decade

Rainer Kleemann

17 papers receiving 750 citations

Peers

Rainer Kleemann
Xiaoyan Chang China
Mhan‐Pyo Yang South Korea
T. Sako Japan
T Gaál Hungary
Brady Gaynor United States
Satoshi Haga Japan
Mustafa Özcan Türkiye
Cheng Xia China
Birgitte Wuyts Belgium
R. K. Rao United States
Xiaoyan Chang China
Rainer Kleemann
Citations per year, relative to Rainer Kleemann Rainer Kleemann (= 1×) peers Xiaoyan Chang

Countries citing papers authored by Rainer Kleemann

Since Specialization
Citations

This map shows the geographic impact of Rainer Kleemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rainer Kleemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rainer Kleemann more than expected).

Fields of papers citing papers by Rainer Kleemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rainer Kleemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rainer Kleemann. The network helps show where Rainer Kleemann may publish in the future.

Co-authorship network of co-authors of Rainer Kleemann

This figure shows the co-authorship network connecting the top 25 collaborators of Rainer Kleemann. A scholar is included among the top collaborators of Rainer Kleemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rainer Kleemann. Rainer Kleemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kleemann, Rainer, et al.. (2006). Investigation of the clinical efficacy, safety and palatability of meloxicam (Metacam) treatment in horses with musculosceletal disorders. Pferdeheilkunde Equine Medicine. 22(4). 420–426. 4 indexed citations
2.
Romero, Rafael Ramírez, et al.. (2004). Clinical efficacy of meloxicam (Metacam) and flunixin (Finadyne) as adjuncts to antibacterial treatment of respiratory disease in fattening cattle.. PubMed. 117(7-8). 304–9. 17 indexed citations
3.
Schneider, Thomas, et al.. (2004). Investigation on the clinical efficacy and safety of meloxicam (Metacam) in the treatment of non-infectious locomotor disorders in pigs.. PubMed. 116(9-10). 421–6. 26 indexed citations
4.
Kleemann, Rainer, et al.. (2003). Investigation on the efficacy of meloxicam in sows with mastitis–metritis–agalactia syndrome. Journal of Veterinary Pharmacology and Therapeutics. 26(5). 355–360. 66 indexed citations
5.
Fuentes, Virginia Luis, et al.. (2002). A Double-Blind, Randomized, Placebo-Controlled Study of Pimobendan in Dogs with Dilated Cardiomyopathy. Journal of Veterinary Internal Medicine. 16(3). 255–255. 18 indexed citations
6.
Fuentes, Virginia Luis, et al.. (2002). A Double-Blind, Randomized, Placebo-Controlled Study of Pimobendan in Dogs with Dilated Cardiomyopathy. Journal of Veterinary Internal Medicine. 16(3). 255–261. 67 indexed citations
7.
Kleemann, Rainer, et al.. (1999). Depletion kinetics of clenbuterol hydrochloride in competition horses. Equine Veterinary Journal. 31(4). 339–341. 4 indexed citations
8.
Kleemann, Rainer, et al.. (1998). Impact of Dietary Fat on Th1/Th2 Cytokine Gene Expression in the Pancreas and Gut of Diabetes-prone BB Rats. Journal of Autoimmunity. 11(1). 97–103. 33 indexed citations
9.
10.
Kleemann, Rainer, et al.. (1997). Insulin Therapy of Prediabetes Suppresses TH1 Associated Gene Expression in BB Rat Pancreas. Autoimmunity. 26(1). 1–6. 17 indexed citations
11.
12.
Kolb, Hubert, et al.. (1996). Cytokine gene expression in the BB rat pancreas: natural course and impact of bacterial vaccines. Diabetologia. 39(12). 1448–1454. 42 indexed citations
13.
Bellmann, Kerstin, A Wenz, J Radons, et al.. (1995). Heat shock induces resistance in rat pancreatic islet cells against nitric oxide, oxygen radicals and streptozotocin toxicity in vitro.. Journal of Clinical Investigation. 95(6). 2840–2845. 134 indexed citations
14.
Rothe, H., Ulrich F. Schade, Rainer Kleemann, et al.. (1994). Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4. Diabetologia. 37(11). 1154–1158. 101 indexed citations
15.
Rothe, H., Ulrich F. Schade, Rainer Kleemann, et al.. (1994). Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4. Diabetologia. 37(11). 1154–1158. 11 indexed citations
16.
Rothe, H., Ulrich F. Schade, Rainer Kleemann, et al.. (1994). Rapid communications Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4. 1 indexed citations
17.
Kleemann, Rainer, Helga Rothe, Victoria Kolb-Bachofen, et al.. (1993). Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats. FEBS Letters. 328(1-2). 9–12. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoyan Chang Breakdown of academic impact, for papers by Mhan‐Pyo Yang Breakdown of academic impact, for papers by T. Sako Breakdown of academic impact, for papers by T Gaál Breakdown of academic impact, for papers by Brady Gaynor Breakdown of academic impact, for papers by Satoshi Haga Breakdown of academic impact, for papers by Mustafa Özcan Breakdown of academic impact, for papers by Cheng Xia Breakdown of academic impact, for papers by Birgitte Wuyts Breakdown of academic impact, for papers by R. K. Rao
Rankless by CCL
2026